Abstract

Sotalol 5-mg/mL Oral Suspension

Author(s): Allen Loyd V Jr

Issue: Sep/Oct 2011 - Volume 15, Number 5

Page(s): 425

Download in electronic PDF format for $75
  • Sotalol 5-mg/mL Oral Suspension Page 1

Abstract

A formulation for preparing Sotalol 5-mg/mL Oral Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • formulation
  • nonselective beta blocker
  • sotalol
  • ventricular arrhythmia
  • supraventricular tachycardia

Related Categories

  • FORMULATIONS
  • CARDIOLOGY
  • DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Sep/Oct 2011
Pg. 425
Sotalol 5-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Mar/Apr 2006
Pg. 144
Sotalol Hydrochloride 5-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
Nov/Dec 2004
Pg. 462-465
Basics of Compounding for Cough
Author(s): Allen Loyd V Jr
Sep/Oct 2005
Pg. 402-406
Stability of Sotalol Hydrochloride in Extemporaneously Prepared Oral Suspension Formulations
Author(s): Sidhom Madiha B, Rivera Nadya, Almoazen Hassan, Taft David R, Kirschenbaum Harold L
Nov/Dec 2018
Pg. 516-526
Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF pH4
Author(s): Polonini Hudson, da Silva Sharlene Loures, Brandão Marcos Antônio Fernandes, Bauters Tiene, De Moerloose Barbara, Ferreira Anderson de Oliveira
May/Jun 2020
Pg. 194-197
Compounded Beta-blocker Nasal Spray for Treatment of Acute Migraine: A New Therapeutic Modality
Author(s): Hagan John C III, Everett Eric, Chamberlain Tyler
Jul/Aug 2016
Pg. 328-332
Y-site Physical Compatibility of Beta-blocker Infusions with Intensive Care Unit Admixtures
Author(s): Foushee Jaime A, Meredith Pmichaele, Fox Laura M, Grace EdwardE
Sep/Oct 2022
Pg. 364-368
A Compendium of Compounding Agents and Formulations, Part 5: Timolol and Beta-glucans
Author(s): Riepl Mike
Nov/Dec 2011
Pg. 458-463
Infantile Hemangiomas, Part 2: Topical Treatment with Beta Blockers
Author(s): Zur Eyal
May/Jun 2006
Pg. 220
Carvedilol 1.25-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr
Mar/Apr 2012
Pg. 160
Labetalol Hydrochloride 5-mg/mL Injection
Author(s): Allen Loyd V Jr
Nov/Dec 2021
Pg. 503
Metoprolol Tartrate 10 mg/mL in SyrSpend SF pH4 Oral Suspension
Author(s): Allen Loyd V Jr
Mar/Apr 2022
Pg. 148
Propranolol 2 mg/mL and 5 mg/mL in Ora-Blend SF Suspension
Author(s): Allen Loyd V Jr
Sep/Oct 2012
Pg. 420
Esmolol Hydrochloride 10-mg/mL Injection
Author(s): Allen Loyd V Jr
Nov/Dec 2021
Pg. 504
Propranolol 2 mg/mL or 5 mg/mL in Ora-Sweet
Author(s): Allen Loyd V Jr
Jan/Feb 2014
Pg. 68
Procainamide Hydrochloride 100-mg/mL Injection
Author(s): Allen Loyd V Jr
Sep/Oct 2008
Pg. 455
Propafenone 1.5-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
Sep/Oct 2023
Pg. 420
Nitazoxanide 20-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr
May/Jun 1997
Pg. 183
Spironolactone 5-mg/mL with Hydrochlorothiazide 5-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr